A5012298795- Gastrointestinal disorders and treatments
- Inflammatory Bowel Disease
- Neuroendocrine Tumor Research Advances
- IgG4-Related and Inflammatory Diseases
- Single-cell and spatial transcriptomics
- Biosimilars and Bioanalytical Methods
- SARS-CoV-2 and COVID-19 Research
- Immune responses and vaccinations
- Pharmaceutical studies and practices
- Adolescent and Pediatric Healthcare
- Health Systems, Economic Evaluations, Quality of Life
University of Mississippi Medical Center
2022-2025
Jackson Memorial Hospital
2022-2025
Abstract SARS-CoV-2 infection and COVID-19 disease vary with respect to viral variant host vaccination status. However, how vaccines, emergent variants, their intersection shift responses in the human nasal mucosa remains uncharacterized. We others have shown during first wave that a muted epithelial interferon response at site of underlies severe COVID-19. sought further understand upper airway cell subsets states associate phenotypes across variants vaccination. Here, we integrated new...
Introduction: Advanced IBD therapies including biological agents (infliximab, adalimumab, ustekinumab, golimumab, certolizumab pegol, and vedolizumab) oral inhibitors (tofacitinib ozanimod) have become mainstays of treatment for moderate to severe Crohn’s disease ulcerative colitis. Although providers anecdotal evidence that delays in insurance approval these treatments might result adverse outcomes, the rate hospitalization surgery during prior process not been formally evaluated. This...